3-aminopropyl functionalized magnesium phyllosilicate as an organoclay based drug carrier for improving the bioavailability of flurbiprofen

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 4147-4155

  Yang, Liang ^a   Choi, Soo Kyung ^b   Shin, Hyun Jae ^b   Han, Hyo Kyung ^a  

^a Dongguk University   (South Korea)

^b Chosun University   (South Korea)

Author keywords

Aminopropyl functionalized magnesium phyllosilicate; Oral bioavailability; Organic clay; Poorly water soluble drugs

Indexed keywords

3 AMINOPROPYL FUNCTIONALIZED MAGNESIUM PHYLLOSILICATE; DRUG CARRIER; FLURBIPROFEN; SILICATE; UNCLASSIFIED DRUG; WATER;

ACIDITY; ANIMAL EXPERIMENT; ARTICLE; CLAY; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; GEL; MALE; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; RAT; TIMED DRUG RELEASE;

AMINOPROPYL FUNCTIONALIZED MAGNESIUM PHYLLOSILICATE; ORAL BIOAVAILABILITY; ORGANIC CLAY; POORLY WATER-SOLUBLE DRUGS;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; DRUG CARRIERS; FLURBIPROFEN; HYDROGEN-ION CONCENTRATION; MAGNESIUM SILICATES; MALE; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY;

EID: 84887360741     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S51756     Document Type: Article

References (21)

1. Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother. 2004;58(3):173-182.
2. da Fonseca MG, Airoldi C. Phyllosilicate-like structure anchored silylating agents: calorimetric data on divalent cation-aminated centre interactions in the lamellar cavity. J Chem Soc Dalton. 1999(21);3687-3692.
3. Sales JAA, Petrucelli GC, Oliveira FJVE, Airoldi C. Some features associated with organosilane groups grafted by the sol-gel process onto synthetic talc-like phyllosilicate. J Colloid Interface Sci. 2006(1);297: 95-103.
4. Melo MA Jr, Oliveira FJVE, Airoldi C. Novel talc-like nickel phyllosilicates functionalized with ethanolamine and diethanolamine. Appl Clay Sci. 2008;42(1-2):130-136.
5. da Fonseca MG, Da Silva Filho EC, Machado RSA Jr, Arakaki LNH, Espinola JGP, Airoldi C. Zinc phyllosilicates containing amino pendant groups. J Solid State Chem. 2004;177(7): 2316-2322.
6. Burkett SL, Press A, Mann S. Synthesis, characterization, and reactivity of layered inorganic-organic nanocomposites based on 2:1 trioctahedral phyllosilicates. Chem Mater. 1997;9(5):1071-1073.
7. Mann S, Burkett SL, Davis SA, et al. Sol-gel synthesis of organized matter. Chem Mater. 1997;9(11):2300-2310.
8. Bromley KM, Patil AJ, Seddon AM, Booth P, Mann S. Bio-functional mesolamellar nanocomposites based on inorganic/polymer intercalation in purple membrane (bacteriorhodopsin) films. Adv Mater. 2007;19(18):2433-2438.
9. Holmström SC, Patil AJ, Butler M, Mann S. Influence of polymer co-intercalation on guest release from aminopropyl-functionalized magnesium phyllosilicate mesolamellar nanocomposites. J Mater Chem. 2007;17:3894-3900.
10. Mann S. Self-assembly and transformation of hybrid nano-objects and nanostructures under equilibrium and non-equilibrium conditions. Nat Mater. 2009;8:781-792.
11. Patil AJ, Muthusamy E, Mann S. Fabrication of functional protein-organoclay lamellar nanocomposites by biomolecule-induced assembly of exfoliated aminopropyl-functionalized magnesium phyllosilicates. J Mater Chem. 2005;15:3838-3843.
12. Patil AJ, Muthusamy E, Mann S. Synthesis and self-assembly of organoclay-wrapped biomolecules. Angew Chem Int Ed Engl. 2004;43: 4928-4933.
13. Patil AJ, Li M, Dujardin E, Mann S. Novel bioinorganic nanostructures based on mesolamellar intercalation or single-molecule wrapping of DNA using organoclay building blocks. Nano Lett. 2007;7(9):2660-2665.
14. Han HK, Lee YC, Lee MY, Patil AJ, Shin HJ. Magnesium and calcium organophyllosilicates: Synthesis and in vitro cytotoxicity study. ACS Appl Mater Interfaces. 2011;3(7):2564-2572.
15. Richy F, Rabenda V, Mawet A, Reginster JY. Flurbiprofenin the symptomatic management of rheumatoid arthritis: a valuable alternative. Int J Clin Pract. 2007;61(8):1396-1406.
16. Kang JH, Oh DH, Oh YK, Yong CS, Choi HG. Effects of solid carriers on the crystalline properties, dissolution and bioavailability of flurbiprofen in solid self-nanoemulsifying drug delivery system (solid SNEDDS). Eur J Pharm Biopharm. 2012;80(2):289-297.
17. Oh DH, Kang JH, Kim DW, et al. Comparison of solid self-microemulsifying drug delivery system (solid SMEDDS) prepared with hydrophilic and hydrophobic solid carrier. Int J Pharm. 2011;420(2):412-418.
18. Pudipeddi M, Serajuddin ATM, Grant DJW, Stahl PH. Solubility and dissolution of weak acids, bases, and salts. In: Stahl, PH, Wermuth, CG, editors. Handbook of Pharmaceutical Salts: Properties, Selection, and Use. New York:Wiley-VCH; 2002:19-39.
19. Serajuddin AT. Salt formation to improve drug solubility. Adv Drug Deliv Rev. 2007;59(7):603-616.
20. Serajuddin AT, Jarowski CI. Effect of diffusion layer pH and solubility on the dissolution rate of pharmaceutical acids and their sodium salts II: Salicylic acid, theophylline, and benzoic acid. J Pharm Sci. 1985;74(2): 148-154.
21. Pignatello R, Ferro M, Puglisi G. Preparation of solid dispersions of nonsteroidal anti-inflammatory drugs with acrylicpolymers and studies on mechanisms of drug-polymer interactions. AAPS Pharm Sci Tech. 2002;3(2):E10.